We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Rahway, New Jersey-based pharmaceutical maker - Announces that the Phase 3 KEYNOTE-A18 trial, showed KEYTRUDA, in comb ...
Merck & Co Inc announced on Tuesday that its cancer treatment Keytruda with chemotherapy has been granted priority re ...
Merck & Co Inc on Thursday said sales jumped in the fourth quarter and in all of 2023 as it eyes future growth Sales ...
LC - London-based venture capital firm investing in "breakthrough" biotechnology companies - Expects USD18.6 million n ...
Merck & Co Inc on Monday said it is diversifying its oncology pipeline as it has entered an agreement to buy Harpoon ...
Astellas Pharma Inc, Merck & Co Inc and Pfizer Inc on Friday announced expanded approval in the US for Keytruda combi ...
Merck & Co Inc on Friday said its drug belzutifan was approved by the US Food & Drug Administration. The news follow ...
Merck & Co Inc on Friday and Monday updated investors on two developments regarding its cancer treatment, Keytruda. ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.8 | 1.44115292234 | 124.9 | 127.1 | 124.9 | 877831 | 127.06431551 | DE |
4 | -5.1 | -3.86949924127 | 131.8 | 131.8 | 124.9 | 249035 | 127.08924752 | DE |
12 | 2.3 | 1.84887459807 | 124.4 | 131.8 | 119 | 247920 | 126.37075287 | DE |
26 | 22.2 | 21.2440191388 | 104.5 | 131.8 | 100.9 | 186484 | 120.00793287 | DE |
52 | 10.3 | 8.84879725086 | 116.4 | 131.8 | 100.9 | 172697 | 115.39946329 | DE |
156 | 49.45 | 64.0129449838 | 77.25 | 131.8 | 71 | 108306 | 103.64577592 | DE |
260 | 76.7 | 153.4 | 50 | 131.8 | 50 | 79414 | 101.81079047 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions